Galectin Therapeutics Inc... (GALT)
NASDAQ: GALT
· Real-Time Price · USD
5.05
-0.14 (-2.70%)
At close: Oct 16, 2025, 3:59 PM
5.10
0.99%
After-hours: Oct 16, 2025, 05:17 PM EDT
-2.70% (1D)
| Bid | 5.05 |
| Market Cap | 323.46M |
| Revenue (ttm) | 36K |
| Net Income (ttm) | -40.34M |
| EPS (ttm) | -0.64 |
| PE Ratio (ttm) | -7.89 |
| Forward PE | -11.27 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.25 |
| Volume | 257,637 |
| Avg. Volume (20D) | 302,118 |
| Open | 5.14 |
| Previous Close | 5.19 |
| Day's Range | 4.96 - 5.24 |
| 52-Week Range | 0.73 - 6.55 |
| Beta | 0.86 |
| Ex-Dividend Date | n/a |
About GALT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GALT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GALT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+60.4%
Galectin Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
6 months ago
-19.74%
Galectin Therapeutics shares are trading lower following a FY24 EPS miss.
